249 related articles for article (PubMed ID: 24793304)
1. Emerging drugs for neuropathic pain.
Gilron I; Dickenson AH
Expert Opin Emerg Drugs; 2014 Sep; 19(3):329-41. PubMed ID: 24793304
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs in neuropathic pain.
Gilron I; Coderre TJ
Expert Opin Emerg Drugs; 2007 Mar; 12(1):113-26. PubMed ID: 17355217
[TBL] [Abstract][Full Text] [Related]
4. Sigma-1 receptors and animal studies centered on pain and analgesia.
Davis MP
Expert Opin Drug Discov; 2015; 10(8):885-900. PubMed ID: 26037105
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
Papanas N; Ziegler D
Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
[TBL] [Abstract][Full Text] [Related]
6. New investigational drugs for the treatment of neuropathic pain.
Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
[TBL] [Abstract][Full Text] [Related]
7. Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions - a review of clinical trials.
Knezevic NN; Jovanovic F; Candido KD; Knezevic I
Expert Opin Pharmacother; 2020 Dec; 21(18):2231-2248. PubMed ID: 32772737
[TBL] [Abstract][Full Text] [Related]
8. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.
Sawynok J
Eur J Pain; 2014 Apr; 18(4):465-81. PubMed ID: 24108446
[TBL] [Abstract][Full Text] [Related]
9. Effects of S 38093, an antagonist/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats.
Chaumette T; Chapuy E; Berrocoso E; Llorca-Torralba M; Bravo L; Mico JA; Chalus M; Eschalier A; Ardid D; Marchand F; Sors A
Eur J Pain; 2018 Jan; 22(1):127-141. PubMed ID: 28877402
[TBL] [Abstract][Full Text] [Related]
10. New and developing drugs for the treatment of neuropathic pain in diabetes.
Freeman R
Curr Diab Rep; 2013 Aug; 13(4):500-8. PubMed ID: 23771401
[TBL] [Abstract][Full Text] [Related]
11. Zucapsaicin for the treatment of neuropathic pain.
Sałat K; Jakubowska A; Kulig K
Expert Opin Investig Drugs; 2014 Oct; 23(10):1433-40. PubMed ID: 25171227
[TBL] [Abstract][Full Text] [Related]
12. MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.
Naguib M; Diaz P; Xu JJ; Astruc-Diaz F; Craig S; Vivas-Mejia P; Brown DL
Br J Pharmacol; 2008 Dec; 155(7):1104-16. PubMed ID: 18846037
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
Rodrigues-Filho R; Campos MM; Ferreira J; Santos AR; Bertelli JA; Calixto JB
Brain Res; 2004 Aug; 1018(2):159-70. PubMed ID: 15276874
[TBL] [Abstract][Full Text] [Related]
14. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
Cavalli E; Mammana S; Nicoletti F; Bramanti P; Mazzon E
Int J Immunopathol Pharmacol; 2019; 33():2058738419838383. PubMed ID: 30900486
[TBL] [Abstract][Full Text] [Related]
15. Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.
Smith MT; Anand P; Rice ASC
Pain; 2016 Feb; 157 Suppl 1():S33-S41. PubMed ID: 26785154
[TBL] [Abstract][Full Text] [Related]
16. [The cannabinoid system and pain: towards new drugs?].
Beltramo M
J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
[TBL] [Abstract][Full Text] [Related]
17. Animal models of neuropathic pain.
Jaggi AS; Jain V; Singh N
Fundam Clin Pharmacol; 2011 Feb; 25(1):1-28. PubMed ID: 20030738
[TBL] [Abstract][Full Text] [Related]
18. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.
Kiso T; Watabiki T; Sekizawa T
Eur J Pharmacol; 2020 Aug; 881():173194. PubMed ID: 32445705
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.
Kushnarev M; Pirvulescu IP; Candido KD; Knezevic NN
Expert Opin Investig Drugs; 2020 Mar; 29(3):259-271. PubMed ID: 32070160
[No Abstract] [Full Text] [Related]
20. Discontinued neuropathic pain therapy between 2009-2015.
Knezevic NN; Cicmil N; Knezevic I; Candido KD
Expert Opin Investig Drugs; 2015; 24(12):1631-46. PubMed ID: 26472477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
